Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Arvinas, Inc.
IPO Date: September 24, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $591.44M
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.12 | 2.96%
Avg Daily Range (30 D): $0.24 | 3.14%
Avg Daily Range (90 D): $0.48 | 3.39%
Institutional Daily Volume
Avg Daily Volume: .48M
Avg Daily Volume (30 D): 2.27M
Avg Daily Volume (90 D): 1.64M
Trade Size
Avg Trade Size (Sh.): 66
Avg Trade Size (Sh.) (30 D): 96
Avg Trade Size (Sh.) (90 D): 88
Institutional Trades
Total Inst.Trades: 2,925
Avg Inst. Trade: $2.2M
Avg Inst. Trade (30 D): $1.98M
Avg Inst. Trade (90 D): $1.89M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.68M
Avg Closing Trade (30 D): $2.32M
Avg Closing Trade (90 D): $2.45M
Avg Closing Volume: 72.25K
       
News
Apr 4, 2025 @ 11:00 AM
Arvinas Presents First-in-Human Data for Investiga...
Source: N/A
Mar 27, 2025 @ 11:00 AM
Arvinas Announces Oral Presentation at 2025 Intern...
Source: Arvinas, Inc.
Jan 21, 2025 @ 9:29 AM
2 Growth Stocks That Could Rocket Higher in the Fi...
Source: Cory Renauer
Dec 10, 2024 @ 6:23 PM
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63%...
Source: Vandana Singh
Nov 27, 2024 @ 12:00 PM
Arvinas to Present at Piper Sandler 36th Annual He...
Source: N/A
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $-4.79 $-.68 $-.49
Diluted EPS $-4.79 $-.68 $-.49
Revenue $ 161.1M $ 102.4M $ 76.5M
Gross Profit $ $ $
Net Income / Loss $ -308.6M $ -49.2M $ -35.2M
Operating Income / Loss $ -357.4M $ -60.3M $ -48.5M
Cost of Revenue $ $ $
Net Cash Flow $ -34M $ -75.1M $ 66.8M
PE Ratio